Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database
Go back to Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database| (NASDAQ: IMDX) | Delayed: 3.37 +0.09 (2.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.28 | 52 Week High | $ | |||
| Open | $3.29 | 52 Week Low | $ | |||
| Day High | $3.44 | P/E | N/A | |||
| Day Low | $3.19 | EPS | $ | |||
| Volume | 156,357 | |||||



